Immune checkpoint inhibitor-induced inflammatory arthritis: a qualitative study identifying unmet patient needs and care gaps

BACKGROUND: Patients treated for cancer with immune checkpoint inhibitors (ICI) may develop autoimmune adverse events, including ICI-induced inflammatory arthritis (IA). ICI-induced IA treatment requires balancing immune activation to fight cancer and immune modulation to control autoimmunity. Our o...

Descripción completa

Detalles Bibliográficos
Autores principales: Cappelli, Laura C., Grieb, Suzanne M., Shah, Ami A., Bingham, Clifton O., Orbai, Ana-Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395372/
https://www.ncbi.nlm.nih.gov/pubmed/32766511
http://dx.doi.org/10.1186/s41927-020-00133-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395372/
https://www.ncbi.nlm.nih.gov/pubmed/32766511
http://dx.doi.org/10.1186/s41927-020-00133-8

Ejemplares similares